NCT00464945View on ClinicalTrials.gov

Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Pneumococcal Vaccines
Interventions
BIOLOGICAL

13-valent Pneumococcal Conjugate Vaccine

1 dose at 2,3,4 and 12 months of age

Trial Locations (9)

87-100

Torun

30-663

Krakow

31-442

Krakow

41-103

Siemianowice Śląskie

21-100

Lubartowie

20-044

Lublin

01-184

Warsaw

91-347

Lodz

93-338

Lodz

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00464945 - Wyeth Study To Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants | Biotech Hunter | Biotech Hunter